Correction to: Real-world outcomes of ponatinib in heavily pretreated patients with chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia
Annals of Hematology · 24.10.2026 · 105 (11)
DOI: 10.1007/s00277-026-07311-7 ↗Kurz gefasst
Korrektur in der Zeitschrift Annals of Hematology, online erschienen am 24.10.2026. Verfasst von Seok Lee und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Ewha Womans University Mokdong Hospital, Seoul, Republic of Korea. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Hematology, Ewha Womans University Mokdong Hospital, Seoul, Republic of Korea.
- Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, Jeollanam-do, Republic of Korea.
- Division of Hematology, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
- Division of Hematology-Oncology, Department of Internal Medicine, Pusan National University Hospital, Busan, Republic of Korea.
- Division of Oncology and Hematology, Department of Internal Medicine, Wonju Severance Christian Hospital, Wonju, Republic of Korea.
- Department of Hematology/Oncology, Kyungpook National University Hospital, Daegu, Republic of Korea.
Zitieren
APA
Lee, S., Kim, H. J., Cheong, J. W., Shin, H. J., Kong, J. H., Sohn, S. K., Yoon, S. S., Zang, D. Y., Jung, C. W., Kim, J. A., Lee, S. E., Lee, W. S., Choi, Y., Kim, I., Han, J. J., Kim, M. K., Chong, S. Y., Kim, D. J., Jo, D. Y., …, & Kim, D. W. (2026). Correction to: Real-world outcomes of ponatinib in heavily pretreated patients with chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. Annals of Hematology, 105(11). https://doi.org/10.1007/s00277-026-07311-7
Vancouver
Lee S, Kim HJ, Cheong JW, Shin HJ, Kong JH, Sohn SK, et al. Correction to: Real-world outcomes of ponatinib in heavily pretreated patients with chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. Annals of Hematology. 2026;105(11). doi:10.1007/s00277-026-07311-7
BibTeX
@article{Lee2026,
author = {Lee, Seok and Kim, Hyeoung-Joon and Cheong, June-Won and Shin, Ho-Jin and Kong, Jee Hyun and Sohn, Sang Kyun and Yoon, Sung-Soo and Zang, Dae Young and Jung, Chul Won and Kim, Jeong-A and Lee, Sung-Eun and Lee, Won Sik and Choi, Yunsuk and Kim, Inho and Han, Jae Joon and Kim, Min Kyoung and Chong, So Young and Kim, Da Jung and Jo, Deog-Yeon and Kim, Hawk and Kwak, Jae-Yong and Lee, Je-Hwan and Uhm, Jieun and Lee, Sewon and Lee, Min-Yi and Kim, Dong-Wook},
title = {Correction to: Real-world outcomes of ponatinib in heavily pretreated patients with chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia},
journal = {Annals of Hematology},
year = {2026},
volume = {105},
number = {11},
doi = {10.1007/s00277-026-07311-7}
}
EUVIMED